Summary.-A number of tests have been described which are thought to be capable of identifying carcinogens without using the actual induction of cancer as an endpoint. This study compares the performance of 6 such tests on a selection of 120 organic chemicals. The tests studies were: (1) mutation of Salmonella typhimurium; (2) cell transformation; (3) degranulation of endoplasmic reticulum; (4) sebaceous gland suppression; (5) tetrazolium reduction and (6) subcutaneous implant. A further 4 tests were examined briefly, but were not included in the complete evaluation.
tion.
The chemicals were classified into carcinogens (58) and non-carcinogens (62) on the basis of published experimental data, and into 1 of 4 broad chemical classes.
There was considerable variation between tests in their ability to predict carcinogenicity, with the cell-transformation test and the bacterial-mutation test being the most accurate (94% and 93% accurate respectively). These 2 tests were considered to be of general use in screening, since they were clearly more accurate than the others. Statistical consideration of various combinations of these tests showed that the use of cell transformation and bacterial mutation together, provide an advantage over the use of either test alone. The inclusion of the other 4 tests in a screening battery predictably resulted in a great increase in overall inaccuracy and loss of discrimination, even though the detection of carcinogens is improved. All the tests were shown to generate both false positive and false negative results, a situation which may be controlled by the use, where possible, of appropriate chemical-class controls, to identify the test which is optimal for the class of chemical under test. Structural analogy may have a part to play in the rapid detection of environmental carcinogens, and some general guidelines for its use are given.
INFORMATION about the carcinogenic activity of chemicals has been gathered from epidemiological studies and animal experimentation. Epidemiological studies based on geographical variations in cancer incidence have indicated that many human cancers are caused, mediated or modified by environmental factors (Higginson, 1969; Boyland, 1969; Wynder and Mabuchi, 1972; Higginson and Muir, 1973; Cairns, 1975) . Although one of the factors is thought to be the presence of naturally occurring and man-made carcinogens in the environment (Clayson, 1962; Hueper and Conway, 1964; Boyland, 1969; Dinman, 1974; Weisburger and Williams 1975) those human cancers which are known to be caused by chemicals are few in number. These cancers, which have been associated with specific chemicals have generally been limited to groups of people in a particular industry or occupation and, in total, make up only a small part of the cancer burden in man. Because ofthe retrospective nature ofepidemiology, a carcinogenic hazard cannot be anticipated. Furthermore, epidemiological studies are expensive and time-consuming, and the gathering of complete and statistically analysable data is difficult.
Many hundreds of other chemicals, however, have been shown to be carcinogenic in animals (WHO/IARC publications 1972-75) and are, therefore, potentially carcinogenic to man. Carcinogenesis studies in animals can be used at present to identify potential human carcinogens, but suffer from problems of interpretation due to modifying factors such as diet, variations in spontaneous and induced tumour incidences, species, strain and sex differences. Further disadvantages of animal testing are high costs, protracted duration of such studies and the resultant heavy demands on animals and laboratory resources.
There are many thousands of environmental and industrial chemicals and to test every chemical for carcinogenic activity in animals would obviously be very expensive and impracticable within the foreseeable future. It is for this reason that attempts are being made to develop short term tests with non-cancerous end points to identify carcinogenic chemicals.
There is now a greater understanding of some of the mechanisms involved in chemical carcinogenesis from metabolic and structure-activity correlation studies (Clayson, 1962; Brookes, 1971; Hueper and Conway, 1964; WHO/IARC, 1974; Miller, 1970; Miller and Miller, 1971a , b, 1972 , 1974 Dinman, 1974; Arcos and Argus, 1974) but in no case is there unequivocal knowledge of the molecular target critical to the induction of cancer (Miller, 1970) .
Tests having non-cancerous end-points were often derived from observations on the effects produced by carcinogens, and were adapted to screen chemicals Stoltz et al., 1974; Brookes and de Serres, 1976; Bridges, 1976) . Their chief advantages are rapidity, low cost and simplicity of operation, thereby enabling a large number of chemicals to be tested.
The main disadvantage of any test with a non-cancerous end-point is that the significance of the test response with regard to carcinogenicity must be carefullv assessed. With the exception of the Ames' test no extensive evaluation has been made of any of these tests. Furthermore with the exception of a few reviews (Stoltz et al., 1974; Brookes and de Serres, 1976) no attempt has been made to compare tests.
We consider that detailed examination of the available tests (Stoltz et al., 1974; Montesano et al., 1976; Brookes and de Serres, 1976) for predicting carcinogenicity was impracticable. Instead, several tests were selected for evaluation, bearing in mind the available expertise, facilities and published confidence in the various test procedures. The methods selected for study were the following:
(1) Ames test. Salmonella typhimurium plate-incoporation mutagenicity assay . (2) Cell transformation. Mammalian cell transformation in culture (Styles, 1977) . (3) Rabin's test. Degranulation of rough endoplasmic reticulum from rat liver (Williams and Rabin, 1971 ). (4) Sebaceous-gland test. Mouse-sebaceous-gland suppression (Bock and Mund, 1958) , (5) Tetrazolium-reduction test. Reduction of tetrazolium red by mouse skin (Iversen and Evensen, 1962) . (6) Implant test. Tissue reaction to subcutaneous implants in mice (Westwood and Longstaff, unpublished) .
A further 4 tests were considered, but after a brief evaluation were found to be unsuitable (see Appendix VIII). The 120 chemicals chosen for the validation study were selected from a variety of structural and functional classes, and consisted of 58 carcinogens and 62 noncarcinogens. This paper reports the results of a comparative evaluation carried out on a number of short-term tests purporting to identify chemical carcinogens. The evaluations were also aimed at comparing the tests individually and in groups, in order to arrive at the most useful combination.
SIX TESTS FOR CARCINOGENICITY
A preliminary report has already been published (Purchase et al., 1976 (S-9 mix) according to the method of . Details of the method are given in Appendix II.
Mammalian-cell transformation in culture.-A new technique was developed in which Syrian hamster kidney cells (BHK 21/cl 13) and either human diploid lung fibroblasts (W1-38) or human liver derived cells (Chang) were exposed to 5 different doses of the test compounds in vitro in serum-free liquid tissue-culture medium containing rat postmitochondrial supernatant and cofactors (S-9 mix: Ames et al., 1975) to aid in metabolism of the test compound. Following incubation, cells were centrifuged and the medium containing the compound and microsomes discarded. The cells were resuspended in growth medium. To assess survival following exposure an aliquot (10 Fd) containing about 1000 cells was incubated in liquid medium and colonies counted after 6-8 days. A dose-response curve for survival was constructed and the LC50 calculated. To the remaining cell suspension was added molten agar to give a concentration of 0.3% agar in medium, which allowed the growth of transformed colonies (Macpherson and Montagnier, 1964 Degranulation of rat liver rough endoplasmic reticulum.-The loss of ribosomes from isolated rat liver endoplasmic reticulum (RER) following incubation with carcinogens in vitro, first described by Williams and Rabin (1971) has been quantitatively assayed by radio-tracer techniques (Purchase and Lefevre, 1975) . A statistically significant increase in degranulation of the RER by the test compound, over negative controls was taken to indicate a positive result. The method is described in Appendix IV.
Tetrazolium reduction.-The test was based on that described by Iversen and Evensen (1962) . Samples of mouse skin which had been exposed to the test compound in vivo, were incubated in aqueous solutions of tetrazolium red. Increases in in situ biological reduction of the colourless tetrazolium compound to the coloured formazan were measured spectrophotometrically, and taken to indicate a positive response for the test compound. The method is given in detail in Appendix V.
Mouse-skin sebaceous-gland suppression.- Bock and Mund (1958) -) pairs of compounds in the cell transformation and bacterial mutation tests are given in Fig. 3-6 . 2-Naphthol (4) Dieldrin: 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-endo-1,4-exo-5,8-dimetha- nonaphthalene. (5) Merchlorethamine: bis(2-chloroethyl)methylamine hydrochloride. (6) MNNG: N-methyl-N'-nitro-N-nitrosoguanidine. (7) Bis azo compound: 2,2'-Bis [1-(3-octadecylaminopropylimino) ethyl]-2,2'- [3,3'-dichloro-4,4'-biphenyl- p= pA pA + (1 -p)B A is the probability of obtaining the test result with carcinogens, and B is the probability of obtaining the test result with non-carcinogens. The values for A and B were obtained from this study.
DISCUSSION
The 6 tests compared in this paper were developed in several laboratories and each has been previously validated to different extents. The test which has been most extensively used is that developed by Ames and his colleagues, and results from testing over 300 chemicals have recently been reported . This is the first comparative blind study of several tests carried out in one laboratory.
The results of a validation study of this type will be affected by a variety of factors, which include the choice and classification of chemicals, the inherent reproducibility of the test systems, and the fact that these experiments were not repeated.
The chemicals used in this study were selected to represent a wide range of -The effect of variations in p the prior probability that a compound is a carcinogen (% of carcinogens in the samples being tested) on P, the probability that a compound producing a particular test result is a carcinogen. Curves d and dd for the test result bacterial mutation negative and cell transformation positive; e and ee for bacterial mutation positive and cell transformation negative. Curves d and e as in Fig. 1 . Curves dd and ee are the falsepositive results, calculated from the formula p _
(1-p)B pA + (1 -p)B (symbols as in Fig. 1 ting that 5 of the tests had some ability to discriminate between carcinogens and non-carcinogens. The ratio of positive results for carcinogens and non-carcinogens is a measure of the discriminating power. This ratio, and the ratio for negative results, are given in Table IV only the cell transformation and bacterialmutation tests which combine a high predictive accuracy with a low level of false results (indicated by the high ratios in Table IV dependence suggests that it might be appears at first sight to provide considerworthwhile using a battery of tests for able advantages, particularly if the objecunknown compounds. tive is to increase the probability of detecting all carcinogens. In using results
A test battery from more than one test, the interpreta-
The idea of using a battery of tests tion is relatively easy if all tests agree. 6c.-* -* 2-Naphthylamine;
A---A 1-Naphthylamine. In some cases, hiowever, the tests will not all agree (see Table VI (Purchase et al., 1976) . Using the results obtained in this study, and again making a number of assumptions which are stated later in this discussion, Fig. 1 and 2 have been obtained. Fig. 2 demonstrates the effect of varying the proportion of carcinogens in the compounds tested on the probability that a compound which is positive in the bacterial mutation or cell transformation test is a carcinogen. Two lines are drawn in Fig. 1 ; one for the proportion of carcinogens in the compounds judged as positive and the other for the proportion of non-carcinogens in these compounds where the cell transformation is positive and the bacterial mutation is negative. (The 2 proportions must obviously sum to one.) The lines for the alternative result, namely cell transformation negative and bacterial mutation positive, are very similar and have not been presented in Fig. 2 .
It can be seen from Fig. 1 Fig. 1 . Alternatively, study of the chemical structure of a compound may enable us to make an estimate of the probability of it being a carcinogen, which is equivalent to estimating the proportion of carcinogens in that class of compounds.
The calculations on which the graphs ( Fig. 1 and 2 ) are based make certain assumptions. These are: (a) that the 120 compounds used in this study are representative of the compounds to be tested; (b) that the results of the cell-transformation and bacterial-mutation tests are independent; (c) that the tests have the same degree of reproducibility in this study as they will when used in future and (d) that the classification of the 120 compounds into carcinogens and noncarcinogens is correct.
In a future situation, a number of these assumptions may not be valid; e.g. it is unlikely that the 120 compounds used are representative of all groups of compounds to be tested in future and recent evidence (Huberman et al., 1976) (Boveri, 1914; Bauer, 1928; Burdette, 1955; Brookes and Lawley, 1964; Miller and Miller, 1971a, b; Ames et al., 1973) . The second constraint is that, however many generalized data might be generated to support the predictive accuracy of a given test Purchase et al., 1976; potential mutagenicity of a compound shown to be positive must be considered, and any correlation between positive results in the Ames test and mammalian mutagenicity will need to be established independently. The significance of a positive result in the cell-transformation assay in terms of biological phenomena other than carcinogenicity is not so obvious, although cell transformation too may be a mutational event (Huberman et al., 1976) . The suitability of cell transformation as an indicator of mammalian mutagenicity will also need to be established. With the sebaceous-gland, degranulation, subcutaneous-implant and tetrazolium-reduction tests the significance of a positive result in terms other than carcinogenicity is not immediately apparent.
Although the previously published data for the Ames test and the data generated by this study for both the Ames and celltransformation tests, indicate that both 898 Table II. For example, the CCCP formed by nitrosofolic acid and diphenylnitrosamine was correctly identified only by the Ames, cell-transformation and degranulation tests (Table IX and concerns the selection and optimization of the best test for a particular class of potential carcinogens.
False positives
Although positive results generated for animal non-carcinogens appear to offer a smaller problem, their widespread occurrence would make them significant. Again, there are 2 major potential causes of such results. The first is that the animal study is inadequate. For example, a nonsensitive species may have been selected for testing or the route of administration of the compound failed to maximize its carcinogenic potential. Alternatively the study may have been terminated too soon or the pathology of the animals was inadequate. The latter 2 objections apply particularly to most of the currently known "false-positive" results, as they are often based upon older animal studies, conducted with protocols which would be unacceptable by today's standards. There will, however, remain a nucleus of genuine false-positive predictions due to the gross simplicity of any test when compared to whole animal absorption, distribution, 901 metabolism (both detoxification and carcinogenic activation) and excretion of compounds. Further such tests do not allow for the normal protective mechanisms which operate in vivo, such as DNA repair, immunological surveillance and death prior to overt cancer induction. In particular, the selection of dose levels for an animal study may be critical to the outcome of the experiment, depending upon whether or not such protective mechanisms are maintained intact during the study.
Finally it is too early to discount the possibility that an otherwise reliable test may respond positively to chemicals of a particular type due to specific factors which are not associated with carcinogenicity.
